Articaine Plus Dexmedetomidine in Supraclavicular Block
A Comparative Study Between Articaine Alone Versus Articaine Plus Dexmedetomidine for Ambulatory Orthopedic Surgery Under Supraclavicular Block
Benha University
66 participants
Feb 1, 2024
INTERVENTIONAL
Conditions
Summary
Articaine has emerged as a local anesthetic (LA) that produces sensory and motor blockade shorter than bupivacaine and lower in neurotoxicity than lidocaine. Studies have shown that adding dexmedetomidine to LA produces prolongation of sensory and motor bock duration. Early regain of motor power with adequate analgesia is needed in ambulatory surgery, for early start of physiotherapy. This study was designed to test efficacy of adding dexmedetomidine to articaine on the duration of sensory and motor block.
Eligibility
Inclusion Criteria1
- aged 18-60 years planned for upper limb surgery below the midhumerus with an expected time of less than 90 min usually under tourniquet.
Exclusion Criteria6
- allergies to local anesthetic,
- those with ASA III and IV,
- patients who refuse to participate,
- uncooperative patients,
- patients who have infection at the site of injection,
- patients who have bleeding disorder, and patients on anticoagulant drugs.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
supraclavicular brachial plexus block with articaine 2%
supraclavicular brachial plexus block with articaine 2% in addition with Dexmedetomidine
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06423859